ALDH1A3 and cholangiocarcinoma: Because ALDH1A3 enhances the cell migration ability in cholangiocarcinoma cell lines (Figure 1), we performed the wound-healing assay to examine whether ruxolitinib, an ALDH1A3 inhibitor, inhibited migration.